-
The Past Week's Notable Insider Buys: Amphenol, Aldeyra, Werewolf Therapeutics And More
Saturday, May 8, 2021 - 12:10pm | 1005Read More...Insider buying can be an encouraging signal for potential investors, especially when markets are near all-time highs. Once again, some insiders have taken advantage of initial public offerings. A couple of chief executive officers were among the insiders buying shares this past week. Conventional...
-
Notable Insider Buys Seen In The Past Week: Green Brick, Intel, Teledyne And More
Saturday, January 30, 2021 - 12:10pm | 913Read More...Insider buying can be an encouraging signal for potential investors, especially when markets face uncertainty. Insiders have been taking advantage of secondary offerings recently. An outgoing CEO picked up some shares, as did a renowned hedge fund manager. Conventional wisdom says that insiders...
-
Notable Insider Buys Of The Past Week: Affirm, HEICO, Vector Group, Biotechs And More
Sunday, January 24, 2021 - 8:12am | 964Read More...Insider buying can be an encouraging signal for potential investors, especially when markets face uncertainty. Insiders have been taking advantage of secondary and initial public offerings recently. Biotech companies are once again well represented on this list of notable insider share purchases...
-
Notable Insider Buys Of The Past Week: Conagra Brands Plus Plenty Of Biotech Activity
Saturday, January 16, 2021 - 3:22pm | 954Read More...Insider buying can be an encouraging signal for potential investors, especially when markets face uncertainty. Insiders were taking advantage of secondary offerings as the new year settled in. Biotech companies are well represented on this list of insider share purchases. Conventional wisdom says...
-
Aldeyra CEO Todd Brady Explains Why He Thinks Company Can Have 'Dramatic' Impact In Healthcare
Wednesday, March 9, 2016 - 4:14pm | 1307Read More...Aldeyra Therapeutics Inc (NASDAQ: ALDX) is a small-cap biotech company that specializes in the development of drugs to treat immune and inflammatory diseases. Aldeyra’s most advanced drug is an eye drop treatment for Sjogren-Larsson Syndrome. Benzinga sat down with Aldeyra CEO Todd Brady to...
-
Aldeyra Therapeutics Surges 38%: Here's Why
Monday, February 29, 2016 - 12:11pm | 236Read More...Shares of Aldeyra Therapeutics Inc (NASDAQ: ALDX), a nano-cap biotechnology company, surged higher by more than 38 percent Monday morning after the company reported positive results from a Phase IIa clinical trial. Aldeyra Therapeutics reported that the results from a randomized, parallel-group...
-
IPO Lookout For The Week Of May 5: Alder Biopharma, Cheetah Mobile, GasLog Partners
Monday, May 5, 2014 - 9:45am | 788Read More...Last week's IPOs waited until Friday to debut: Ares Management (NYSE: ARES), Papa Murphy's (NASDAQ: FRSH), Aldeyra Therapeutics (NASDAQ: ALDX), and Scynexis (NASDAQ: SCYX). These IPOs enter a heavily mixed market as the S&P 500 swung between green and red after the employment situation...
-
IPO Lookout For The Week of April 28: Aldeyra Therapeutics, Papa Murphy's & Ares Management
Monday, April 28, 2014 - 1:58pm | 564Read More...U.S. equity offerings for the week of April 28 are still slow. This week the market expects to open three new securities for trading including the delayed IPO of Aldeyra Therapeutics (NASDAQ: ALDX). Other offerings for this week are alternative asset manager Ares Management (NYSE: ARES) and “...
